{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:02:18Z","timestamp":1770753738340,"version":"3.50.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1124\/dmd.116.074898","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T01:25:23Z","timestamp":1487121923000},"page":"457-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone"],"prefix":"10.1016","volume":"45","author":[{"given":"Shotaro","family":"Uehara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakura","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.116.074898_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1248\/jhs.57.164","article-title":"Species Difference between Cynomolgus Monkeys and Humans on Cytochromes P450 2D and 3A-Dependent Drug Oxidation Activities in Liver Microsomes","volume":"57","author":"Emoto","year":"2011","journal-title":"J Health Sci"},{"key":"10.1124\/dmd.116.074898_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/00498250110052120","article-title":"Cooperativity of \u03b1-naphthoflavone in cytochrome P450 3A-dependent drug oxidation activities in hepatic and intestinal microsomes from mouse and human","volume":"31","author":"Emoto","year":"2001","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.074898_bib3","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1021\/bi992372u","article-title":"Amino acid 305 determines catalytic center accessibility in CYP3A4","volume":"39","author":"Fowler","year":"2000","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.116.074898_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1124\/dmd.30.4.452","article-title":"CYP3A4 active site volume modification by mutagenesis of leucine 211","volume":"30","author":"Fowler","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0090-9556(24)15274-9","article-title":"Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression","volume":"27","author":"Gibbs","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib6","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1021\/bi970182i","article-title":"Identification of three key residues in substrate recognition site 5 of human cytochrome P450 3A4 by cassette and site-directed mutagenesis","volume":"36","author":"He","year":"1997","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.116.074898_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0026-895X(24)12112-8","article-title":"Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation","volume":"61","author":"Khan","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.116.074898_bib9","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1080\/00498250600962831","article-title":"Marmoset CYP3A21, a model for human CYP3A4: protein expression and functional characterization of the promoter","volume":"36","author":"Koehler","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.074898_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nrc2015","article-title":"The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis","volume":"6","author":"Nebert","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/dmd.116.074898_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1248\/yakushi.123.369","article-title":"Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR","volume":"123","author":"Nishimura","year":"2003","journal-title":"Yakugaku Zasshi"},{"key":"10.1124\/dmd.116.074898_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/03602532.2015.1011658","article-title":"Regioselective hydroxylation of steroid hormones by human cytochromes P450","volume":"47","author":"Niwa","year":"2015","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.116.074898_bib13","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1124\/dmd.110.032656","article-title":"in vivo probe for studying induction of CYP3A in cynomolgus monkeys","volume":"38","author":"Ohtsuka","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/dmd.108.024679","article-title":"Drug interactions of thalidomide with midazolam and cyclosporine A: heterotropic cooperativity of human cytochrome P450 3A5","volume":"37","author":"Okada","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yrtph.2010.12.003","article-title":"Overview of the marmoset as a model in nonclinical development of pharmaceutical products","volume":"59","author":"Orsi","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1124\/dmd.116.074898_bib16","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \u201cpie\u201d","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/FPC.0b013e3282f313f8","article-title":"CYP3 phylogenomics: evidence for positive selection of CYP3A4 and CYP3A7","volume":"18","author":"Qiu","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.116.074898_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neures.2015.01.011","article-title":"Prospects for genetically modified non-human primate models, including the common marmoset","volume":"93","author":"Sasaki","year":"2015","journal-title":"Neurosci Res"},{"key":"10.1124\/dmd.116.074898_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0167-4838(01)00134-0","article-title":"Assessment of P450 induction in the marmoset monkey using targeted anti-peptide antibodies","volume":"1546","author":"Schulz","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.116.074898_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/dmd.113.055491","article-title":"Expression and characterization of cynomolgus monkey cytochrome CYP3A4 in a novel human embryonic kidney cell-based mammalian system","volume":"42","author":"Selvakumar","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib21","doi-asserted-by":"crossref","first-page":"e100936","DOI":"10.1371\/journal.pone.0100936","article-title":"Callithrix jacchus) transcriptomes using parallel long-read technology and short-read sequencing","volume":"9","author":"Shimizu","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/dmd.116.074898_bib22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/dmd.106.013094","article-title":"Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities","volume":"35","author":"Shimizu","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0090-9556(25)08683-0","article-title":"Progesterone metabolism in hepatic microsomes. Effect of the cytochrome P-450 inhibitor, ketoconazole, and the NADPH 5 alpha-reductase inhibitor, 4-MA, upon the metabolic profile in human, monkey, dog, and rat","volume":"18","author":"Swinney","year":"1990","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/00498254.2015.1057270","article-title":"Simultaneous pharmacokinetics evaluation of human cytochrome P450 probes, caffeine, warfarin, omeprazole, metoprolol and midazolam, in common marmosets (Callithrix jacchus)","volume":"46","author":"Uehara","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.074898_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcp.2016.09.010","article-title":"Oxidation of R- and S-omeprazole stereoselectively mediated by liver microsomal cytochrome P450 2C19 enzymes from cynomolgus monkeys and common marmosets","volume":"120","author":"Uehara","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.074898_bib26","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3109\/00498254.2015.1019595","article-title":"Marmoset cytochrome P450 2D8 in livers and small intestines metabolizes typical human P450 2D6 substrates, metoprolol, bufuralol and dextromethorphan","volume":"45","author":"Uehara","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.074898_bib27","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1124\/dmd.115.066100","article-title":"Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole","volume":"43","author":"Uehara","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/dmd.115.063594","article-title":"Activation and deactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by cytochrome P450 enzymes and flavin-containing monooxygenases in common marmosets (Callithrix jacchus)","volume":"43","author":"Uehara","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib29","first-page":"1","article-title":"Marmoset cytochrome P450 4A11, a novel arachidonic acid and lauric acid \u03c9-hydroxylase expressed in liver and kidney tissues","author":"Uehara","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.074898_bib30","article-title":"Strong induction of cytochrome P450 1A\/3A, but not P450 2B, in cultured hepatocytes from common marmosets and cynomolgus monkeys by typical human P450 inducing agents","author":"Uehara","year":"2016","journal-title":"Drug Metab Lett"},{"key":"10.1124\/dmd.116.074898_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/dmd.109.029710","article-title":"Genetic variants of CYP3A4 and CYP3A5 in cynomolgus and rhesus macaques","volume":"38","author":"Uno","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.06.008","article-title":"Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes","volume":"121","author":"Uno","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.074898_bib33","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1002\/pmic.200800144","article-title":"A gel-free MS-based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomes","volume":"8","author":"Wang","year":"2008","journal-title":"Proteomics"},{"key":"10.1124\/dmd.116.074898_bib34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1124\/dmd.31.6.755","article-title":"Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism","volume":"31","author":"Westlind-Johnsson","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib35","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1124\/dmd.104.000794","article-title":"Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi\/AUC) ratios","volume":"32","author":"Williams","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.074898_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408449209145319","article-title":"The human hepatic cytochromes P450 involved in drug metabolism","volume":"22","author":"Wrighton","year":"1992","journal-title":"Crit Rev Toxicol"},{"key":"10.1124\/dmd.116.074898_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2133\/dmpk.19.120","article-title":"CYP3A5 Contributes significantly to CYP3A-mediated drug oxidations in liver microsomes from Japanese subjects","volume":"19","author":"Yamaori","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.116.074898_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/00498250400021796","article-title":"Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers","volume":"35","author":"Yamaori","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.074898_bib39","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/carcin\/16.9.2167","article-title":"Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes","volume":"16","author":"Yamazaki","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.116.074898_bib40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/prep.2001.1578","article-title":"Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli","volume":"24","author":"Yamazaki","year":"2002","journal-title":"Protein Expr Purif"},{"key":"10.1124\/dmd.116.074898_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/abbi.1997.0302","article-title":"Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes","volume":"346","author":"Yamazaki","year":"1997","journal-title":"Arch Biochem Biophys"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624053650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624053650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.116.074898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:22:39Z","timestamp":1739902959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624053650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0090955624053650"],"URL":"https:\/\/doi.org\/10.1124\/dmd.116.074898","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.116.074898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}